Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,694 | -21,444 | -9,681 | -27,616 | -18,627 |
| Depreciation Amortization | 90 | 45 | 22 | 36 | 15 |
| Accounts payable and accrued liabilities | 948 | 1,285 | 502 | 728 | 1,688 |
| Other Working Capital | 604 | 586 | -742 | 1,044 | 1,294 |
| Other Operating Activity | 2,436 | 1,237 | 846 | 2,968 | 1,008 |
| Operating Cash Flow | $-30,616 | $-18,291 | $-9,053 | $-22,840 | $-14,622 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -22,058 | N/A | 0 | N/A | N/A |
| PPE Investments | -68 | -33 | N/A | -319 | -194 |
| Purchase Sale Intangibles | -120 | -120 | N/A | N/A | N/A |
| Other Investing Activity | -120 | -120 | 0 | -73 | -73 |
| Investing Cash Flow | $-22,246 | $-153 | $0 | $-392 | $-267 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 47,694 | 29,000 | 29,054 | 53,497 | 53,194 |
| Other Financing Activity | 0 | 0 | 0 | -280 | -280 |
| Financing Cash Flow | $47,694 | $29,000 | $29,054 | $53,217 | $52,914 |
| Exchange Rate Effect | -7 | -3 | -4 | -3 | N/A |
| Beginning Cash Position | 38,184 | 38,184 | 38,184 | 8,202 | 8,202 |
| End Cash Position | 33,009 | 48,737 | 58,181 | 38,184 | 46,227 |
| Net Cash Flow | $-5,175 | $10,553 | $19,997 | $29,982 | $38,025 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,616 | -18,291 | -9,053 | -22,840 | -14,622 |
| Capital Expenditure | -68 | -33 | 0 | -319 | -194 |
| Free Cash Flow | -30,684 | -18,324 | -9,053 | -23,159 | -14,816 |